Cargando…
A modified melanoma-molGPA scoring model: assessment of survival after and efficacy of different radiotherapy modalities in patients with melanoma brain metastases
PURPOSE: Patients with malignant melanoma brain metastases (MBMs) have poor prognoses. For MBMs, the Melanoma-molGPA is the most widely used predictive score, but its predictive value remains uncertain in patients fully treated with radiotherapy. We identified MBMs prognostic factors and modified th...
Autores principales: | Wu, Qian, Zhang, Xueqing, Li, Hui, Tang, Lirui, Zeng, Yibin, Lin, Jing, Chen, Yu, Li, Jinluan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310639/ https://www.ncbi.nlm.nih.gov/pubmed/37382755 http://dx.doi.org/10.1007/s12672-023-00722-2 |
Ejemplares similares
-
Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA
por: Kessel, K. A., et al.
Publicado: (2021) -
Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2018) -
Predictors of Lung Adenocarcinoma With Leptomeningeal Metastases: A 2022 Targeted-Therapy-Assisted molGPA Model
por: Zhang, Milan, et al.
Publicado: (2022) -
Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2017) -
Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases
por: Chen, Kaiyan, et al.
Publicado: (2020)